Thailand Kicks Off Covid-19 Vaccine Program With Sinovac Shots Bloomberg 28/02/2021
(Bloomberg)
Thailand started rolling out its Covid-19 inoculation program with Sinovac Biotech Ltd.’s vaccine as the Southeast Asian nation tries to revive its pandemic-hit tourism industry.
Prime Minister Prayuth Chan-Ocha on Sunday presided over the kickoff of the program, with a group of healthcare workers receiving the vaccine, state-owned NBT television network showed in a national live broadcast. Prayuth was not inoculated on Sunday as earlier planned because the Sinovac is not recommended for people of his age, Opas Kankawinpong, director general of the Disease Control Department, told a briefing on Saturday.
Oxford-AstraZeneca Shot Becomes Canada s Third Approved Vaccine
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Oxford-AstraZeneca Shot Becomes Canada s Third Approved Vaccine
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Philippines Clears Sinovac Shots, But Not for Health Workers
Bloomberg 2/22/2021 Andreo Calonzo © Bloomberg Vials of the Sinovac Biotech Ltd. Covid-19 vaccine at the Istora Senayan Sports Complex in Jakarta, Indonesia, on Thursday, Feb. 4, 2021. President Joko Widodo told officials on Sunday that distancing measures needed to be implemented more firmly and consistently to slow the virus spread, adding that military, police and religious leaders must pitch in.
(Bloomberg) The Philippines approved Sinovac Biotech Ltd.’s coronavirus shots for emergency use, paving the way for the nation to get its first vaccine shipment of 600,000 doses possibly within days.
Popular Searches
The Chinese developer’s shots may be effective to prevent Covid-19 and can be used for healthy persons ages 18 to 59, Food and Drug Administration head Eric Domingo said. It isn’t recommended for health workers frequently exposed to the virus due to its 50.4% efficacy for this